Bloomberg's Billion-Dollar Influence: Undermining Global Tobacco Control

Michael Bloomberg's significant financial investment in global tobacco control has sparked a debate over the integrity of institutions like the World Health Organization (WHO) and Vital Strategies. His $1.58 billion funding is said to have transformed these organizations into proponents of a prohibitionist agenda, hindering harm reduction efforts worldwide.

Critics claim that this influence has not only blocked initiatives like 'Tobacco Control 3.0' but also backfired in countries like India, fueling illicit markets as users revert to traditional cigarettes. The inconsistency is evident as Bloomberg-backed groups promote harm reduction in drug policy yet oppose similar measures for tobacco.

Particularly in low- and middle-income countries, Bloomberg's strategies are alleged to increase illicit trade and fail to adjust for local economies and weak enforcement. Experts advocate for more balanced, science-driven policies that emphasize harm-reduction technologies alongside effective legal frameworks.